This concise report on the pharmaceutical pricing and reimbursement policy framework in Cyprus is part of the series of PPRI Pharma Briefs launched by the Pharmaceutical Pricing and Reimbursement Information (PPRI) Secretariat in 2019.The series PPRI Pharma Briefs responds to the interest and needs expressed by policy-makers and technical experts in public authorities responsible for the pricing and reimbursement of medicines to read concise reports of the pharmaceutical policies in other countries. The PPRI Pharma Briefs draw upon the information and data that have been provided by the PPRI network members, in addition to literature and relevant documents, such as legal provisions.